Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug development
Biotech
Recursion streamlines pipeline following merger with Exscientia
Evidently in the mood for spring cleaning, Recursion is clearing out part of its pipeline as it narrows its focus on oncology and rare diseases.
Fraiser Kansteiner
May 5, 2025 11:00am
FDA's CMO steps down
Apr 2, 2025 10:02am
R&D cost per drug up year over year: Deloitte
Mar 25, 2025 12:01am
Servier extends AI drug development pact with Google Cloud
Jan 16, 2025 9:11am
Novo taps Photys for multi-molecule cardiometabolic collab
Dec 18, 2024 7:30am
Roche culls ph. 3 Spark gene therapy in hemophilia
Dec 16, 2024 12:24pm
